Delivery Order SPE2DB22D1002-SPE2DB25FKTE2

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,390.56 firm fixed-price delivery order is for the supply of XELJANZ 5 MG TABLET UU 60S, a prescription medication. The contract has an ultimate completion date of April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,008.51 firm fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2024 and was awarded on December 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,341.52 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication used to treat various conditions. The contract has an ultimate completion date of May 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,665.54, is a Delivery Order for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $4,786.90 firm fixed-price delivery order is for the supply of 4,566,082,539 tablets of XELJANZ 5 MG, a specialty medication. The contract has an ultimate completion date of October 15, 2024 and was awarded on October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET to support federal healthcare programs. The contract, valued at $3,725.39, has a firm fixed price and an ultimate completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,807.39 firm fixed-price delivery order contract is for the supply of XELJANZ 5 MG TABLET UU 60S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,552.82 delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty medication. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,044.08 firm fixed-price delivery order contract is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,776.56 Firm Fixed Price Delivery Order contract is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKTE2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,408.57 firm-fixed-price delivery order is for the supply of XELJANZ 5 MG TABLET UU 60S, a prescription medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The DLA is the primary funding agency for this award, which aligns with the agency's mission to provide medical supplies and services to the U.S. military and other federal healthcare programs.

Generated 1/22/25, 12:49 AM